NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History

NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History

NYSE issues a pre-market daily advisory direct from the trading floor.

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on June 5th

  • Investors are reacting to the May jobs report after the DOW climbed to a record close on Thursday.
  • AstraZeneca (NYSE: AZN) is celebrating its February transfer to the NYSE, the largest transfer by market capitalization in the NYSE's 234-year history.
    • NYSE Live will provide exclusive coverage of CEO Pascal Soriot's remarks.
    • CFO Dr. Aradhana Sarin will discuss the company's financial goals for 2030 in a live interview.
  • Shares of Sunshine Silver Mining & Refining (NYSE: SSMR) jumped by 27% in its NYSE trading debut on Thursday.
  • Stablecoin fintech RedotPay unveiled its first dedicated B2B product, RedotPay Connect, at Money20/20 Europe, which it says will reduce fees by 70% for global merchants.

Opening Bell
AstraZeneca (NYSE: AZN) celebrates its listing on the NYSE

Closing Bell
Futurecorp (NYSE: FTRA) celebrates bringing frontier economies onto public markets

For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com

Sunshine Silver shares jumped 27% in NYSE debut

NYSE Logo

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-update-astrazeneca-celebrates-largest-transfer-in-nyse-history-302792670.html

SOURCE New York Stock Exchange

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2026/05/c2048.html

News Provided by Canada Newswire via QuoteMedia

AZN
The Conversation (0)
AstraZeneca

AstraZeneca

AstraZeneca is a global science-led biopharmaceutical company that focuses on the discovery development and commercialisation of prescription medicines.

AstraZeneca is a global science-led biopharmaceutical company that focuses on the discovery development and commercialisation of prescription medicines. Keep Reading...
Yugo Metals

Government Approval Unlocks High-Grade Polymetallic Project at Petrovo (Sockovac)

Key SummaryThe Government of the Republic of Srpska (Bosnia and Herzegovina) has formally approved Yugo Metals' application for the 100%-owned Petrovo tenement (10km2), unlocking full access to advance what the Company believes is one of the most compelling high-grade polymetallic systems in... Keep Reading...
Red Mountain Mining

Acquisition of “Thompson Falls” High-Grade Antimony Project Adjacent to America’s only Antimony Smelter

Red Mountain Mining Limited (ASX: RMX, US CODE: RMXFF, or “Company”), a Critical Minerals exploration and development company with an established portfolio in Tier-1 Mining Districts in the United States and Australia, is pleased to announce the Company’s newly-acquired Thompson Falls Antimony... Keep Reading...

Last Mile Holdings Ltd. Changes Name to AZN Capital Corp.

AZN Capital Corp. (the "Company" or "AZN") (TSXV: AZN.V) (OTC: AZNVF) announces that it has changed its name from "Last Mile Holdings Ltd." to "AZN Capital Corp." In connection with the name change, the Company's trading symbol on the TSX Venture Exchange will be changed to "AZN.V" upon the... Keep Reading...

Myriad Gets FDA Approval for Metastatic Pancreatic Cancer Drug

Myriad Genetics (NASDAQ:MYGN) confirmed that the US Food and Drug Administration (FDA) has approved its diagnostic test, BRACAnalysis CDx, for use to identify patients with metastatic pancreatic cancer who have a germline BRCA mutation and are candidates for treatment with Lynparza (olaparib).... Keep Reading...

Interactive Chart

Latest Press Releases

Related News